Click any tag below to further narrow down your results
Links
The authors test whether frontier LLMs can predict the next amino acid in obscure bacterial proteins that almost no one writes about, comparing real sequences against shuffled ones to isolate genuine sequence knowledge. The latest Claude models (Opus 5.5 and Fable 5.2) do this well, while GPT, Gemini, and open-weight models stay near zero.
- On 668 little-studied proteins, Fable 5.2 predicts the next residue correctly 54% of the time on real sequences versus 9% on shuffled ones; Opus 5.5 behaves like a dedicated protein language model.
- The gap grows with family size, which fits a model that learned from sequence data rather than from papers, since the effect holds even in families with no publications.
- GPT, Gemini, and seven open-weight models show essentially no gap, and DNA prediction is weak, so the authors conclude the Claude models learned proteins specifically, not genomes.
Anthropic launched Claude Opus 5.5, a new flagship model that matches the performance of their previous Fable 5.1 model while costing 40% less to run. The model shows improvements in safety testing, coding ability, and communication clarity, with faster output generation and lower per-token pricing.
- Pricing drops 40% overall: input tokens at $4/million (down from $5), output at $20/million (down from $25), and cache reads at $0.20/million (down from $0.50)—a 60% reduction on the cache reads that dominate coding workloads.
- Performance gains on real tasks: one tester completed a 680,000-line code migration in under a day that would have taken weeks; another used it to audit and fix a 200,000-line codebase in under three hours versus Opus 5's 20+ hours.
- Safety scores higher on Anthropic's behavioral audit than any previous model tested, with stronger resistance to prompt injection attacks and improved ability to stay within given boundaries.
- Output generation is 30% faster than Opus 5, with a "fast mode" option available at 2.5x speed for additional cost.